International Assets Investment Management LLC Acquires 167,218 Shares of UiPath Inc. (NYSE:PATH)

International Assets Investment Management LLC lifted its holdings in UiPath Inc. (NYSE:PATH) by 1,649.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 177,358 shares of the healthcare company’s stock after purchasing an additional 167,218 shares during the period. International Assets Investment Management LLC’s holdings in UiPath were worth $4,406,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in PATH. Raymond James Financial Services Advisors Inc. increased its stake in shares of UiPath by 3.8% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 40,993 shares of the healthcare company’s stock worth $885,000 after purchasing an additional 1,506 shares during the period. MetLife Investment Management LLC bought a new position in shares of UiPath in the first quarter worth about $184,000. BlackRock Inc. increased its stake in UiPath by 1.9% during the first quarter. BlackRock Inc. now owns 5,316,635 shares of the healthcare company’s stock valued at $114,786,000 after acquiring an additional 99,242 shares during the period. Dimensional Fund Advisors LP bought a new position in UiPath during the first quarter valued at about $534,000. Finally, Canada Pension Plan Investment Board bought a new position in UiPath during the first quarter valued at about $259,000. 62.50% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other UiPath news, CFO Ashim Gupta sold 16,000 shares of the company’s stock in a transaction on Friday, March 15th. The stock was sold at an average price of $22.84, for a total transaction of $365,440.00. Following the transaction, the chief financial officer now owns 87,505 shares of the company’s stock, valued at approximately $1,998,614.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In the last quarter, insiders have sold 72,000 shares of company stock valued at $1,591,360. 31.03% of the stock is currently owned by corporate insiders.

UiPath Price Performance

Shares of PATH opened at $19.41 on Wednesday. The company has a market capitalization of $11.04 billion, a P/E ratio of -114.14 and a beta of 0.96. UiPath Inc. has a one year low of $12.38 and a one year high of $27.87. The business’s 50 day simple moving average is $23.16 and its 200-day simple moving average is $21.47.

UiPath (NYSE:PATH) last announced its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.10. The business had revenue of $405.25 million for the quarter, compared to the consensus estimate of $383.32 million. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. On average, sell-side analysts anticipate that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Canaccord Genuity Group boosted their price target on UiPath from $27.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, March 15th. BMO Capital Markets boosted their price target on UiPath from $24.00 to $28.00 and gave the company a “market perform” rating in a research note on Thursday, March 14th. William Blair assumed coverage on UiPath in a research note on Tuesday, January 2nd. They set an “outperform” rating on the stock. Needham & Company LLC restated a “buy” rating and set a $30.00 price target on shares of UiPath in a research note on Wednesday, March 20th. Finally, Scotiabank lifted their price objective on UiPath from $29.00 to $30.00 and gave the company a “sector perform” rating in a report on Thursday, March 14th. Nine investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $27.41.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.